HALOZYME REPORTS THIRD QUARTER 2022 FINANCIAL AND OPERATING RESULTS

/PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today reported its financial and operating results for the third quarter ended...

Related Keywords

San Diego ,California ,United States ,China ,Japan ,Schottlandt Claudia Styslinger ,Helen Torley ,Bristol Myers Squibb ,Covis Pharma ,Eli Lilly ,Chugai Pharmaceutical Co Ltd ,Member Of The Roche Group ,Linkedin ,Twitter ,Nasdaq ,Halozyme Therapeutics Inc ,Roche Pharmaceuticals China ,Pfizer ,Idorsia Pharmaceuticals ,Prnewswire Halozyme Therapeutics Inc ,Teva Pharmaceutical ,Drug Administration ,Exchange Commission ,Corporate Communications ,Antares Pharma ,Third Quarter Revenue Increased ,Third Quarter Royalty Revenue Increased ,Myasthenia Gravis ,Partner Highlights ,Roche Group ,New Drug Application ,Corporate Highlights ,Convertible Senior Notes ,Quarter Financial Highlights ,Quarterly Update Conference Call ,Horizon Therapeutics ,Viiv Healthcare ,Regarding Use ,Annual Report ,Quarterly Reports ,Investor Relations ,Consolidated Statements ,Halozyme Therapeutics ,Nc ,